[Discussion] amylin is doing more work than we give it credit for
Something I noticed reading old threads that I have not seen said out loud.
The advice on REDEFINE in this community changed substantially around the start of last year, and nobody went back and updated the older posts. So depending on which thread the search engine hands you, you get two contradictory answers with the same confidence.
I have listed what I think the current consensus is below. Correct me — that is the point of posting it.
best — the order this archive was captured in
the co-agonism question is real and interesting
Yeah, amylin is doing different work than GLP-1.
Strongly agree. REDEFINE is phase 5, not final.
the mechanism is different, the side effect profile reflects it
Yeah, amylin is doing different work than GLP-1.
long-acting amylin is co-agonism, different satiety profile
This is correct. The co-agonism is real.
Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.
CagriSema ratios in trials are fixed, do not extrapolate self-mixing
The satiety on amylin analogs is described as physically different. GLP-1 reduces appetite noise, amylin does co-agonism.
Not convinced. The evidence does not support that reading.
- 1Strongly agree. REDEFINE is phase 5, not final.4 comments in this branch · started by u/zeynep_zielinski
- 2CagriSema ratios in trials are fixed, do not extrapolate self-mixing4 comments in this branch · started by u/throwaway_44b1